ALISON BRUNO: Open Payments
NPI 1932483104 · CLEVELAND, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$675 in 31 payments from 9 companies in 2025. Trend: 2023 $583 · 2024 $515 · 2025 $675
Food & beverage: $675
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 8 | $136 |
| Medtronic, Inc. | 1 | $128 |
| E.R. Squibb & Sons, L.L.C. | 6 | $99 |
| AstraZeneca Pharmaceuticals LP | 5 | $96 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $86 |
| PFIZER INC. | 4 | $71 |
| Liquidia Technologies, Inc. | 1 | $26 |
| Alnylam Pharmaceuticals Inc. | 1 | $18 |
| Corcept Therapeutics | 1 | $15 |
Products named: ELIQUIS, LEQVIO, COREVALVE EVOLUT R, FARXIGA, JARDIANCE, YUTREPIA, ONPATTRO, CAMZYOS.
Industry payments across OH — which companies pay providers there.
